A detailed history of Opaleye Management Inc. transactions in Protara Therapeutics, Inc. stock. As of the latest transaction made, Opaleye Management Inc. holds 2,304,262 shares of TARA stock, worth $5.97 Million. This represents 1.23% of its overall portfolio holdings.

Number of Shares
2,304,262
Previous 2,692,594 14.42%
Holding current value
$5.97 Million
Previous $10.8 Million 55.62%
% of portfolio
1.23%
Previous 2.63%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$1.96 - $4.14 $761,130 - $1.61 Million
-388,332 Reduced 14.42%
2,304,262 $4.79 Million
Q4 2022

Feb 10, 2023

SELL
$2.43 - $3.7 $37,599 - $57,250
-15,473 Reduced 0.57%
2,692,594 $7.22 Million
Q3 2022

Nov 14, 2022

BUY
$2.96 - $4.27 $70,744 - $102,052
23,900 Added 0.89%
2,708,067 $7.99 Million
Q2 2022

Aug 15, 2022

BUY
$2.8 - $5.33 $28,380 - $54,024
10,136 Added 0.38%
2,684,167 $8.89 Million
Q1 2022

May 16, 2022

BUY
$4.19 - $6.9 $100,689 - $165,813
24,031 Added 0.91%
2,674,031 $13.7 Million
Q4 2021

Feb 14, 2022

BUY
$6.15 - $7.76 $562,897 - $710,257
91,528 Added 3.58%
2,650,000 $18 Million
Q3 2020

Nov 16, 2020

BUY
$16.76 - $31.89 $5.87 Million - $11.2 Million
350,000 Added 15.85%
2,558,472 $43.1 Million
Q2 2020

Aug 14, 2020

BUY
$22.0 - $60.7 $48.6 Million - $134 Million
2,208,472 New
2,208,472 $64.8 Million

Others Institutions Holding TARA

About Protara Therapeutics, Inc.


  • Ticker TARA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 11,267,400
  • Market Cap $29.2M
  • Description
  • Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the identifying and advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy for the treatment of lymphatic malformations. It also develops intravenous choline chlorid...
More about TARA
Track This Portfolio

Track Opaleye Management Inc. Portfolio

Follow Opaleye Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Opaleye Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Opaleye Management Inc. with notifications on news.